No Data
Bringspring Science and Technology (300290.SZ): Expected loss of 1 million yuan to 13 million yuan in 2024.
On January 22, Gelonghui reported that Bringspring Science and Technology (300290.SZ) expects a loss of 1 million to 13 million yuan in 2024, with a non-recurring loss of 18 million to 30 million yuan. On one hand, affected by the adjustment of the Healthcare Informatization industry, the upgrade of informatization functions, increased customer customization demands, the delivery of certain projects, and extended payment cycles have led to a decline in the company's overall revenue and gross margin, resulting in a year-on-year decrease in net income; on the other hand, facing fierce market competition, the company adheres to a long-term development Global Strategy, continuously increasing investment in product R&D, which has simultaneously impacted net income in the short term.
Rongke Technology: 2024 Annual Results Forecast
Revenues Not Telling The Story For Bringspring Science and Technology Co., Ltd. (SZSE:300290)
Bringspring Science and Technology (300290.SZ): Currently has not yet involved in Digital Currency and cross-border payment Business.
On December 11, Gelonghui reported that Bringspring Science and Technology (300290.SZ) stated on the investor interaction platform that the company focuses on Healthcare Informatization and Smart City as its main businesses and has not yet involved in Digital Currency and cross-border payment Business.
Bringspring Science and Technology Co., Ltd.'s (SZSE:300290) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
There's Been No Shortage Of Growth Recently For Bringspring Science and Technology's (SZSE:300290) Returns On Capital
Risks To Shareholder Returns Are Elevated At These Prices For Bringspring Science and Technology Co., Ltd. (SZSE:300290)
